Article
A human monoclonal antibody neutralizes SARS-CoV-2 Omicron variants by targeting the upstream region of spike protein HR2 motif
2024-02-09
Abstract excerpt
The continuous emergence of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants means there is a need to explore additional strategies to develop broad-spectrum vaccines or therapeutics for individuals remaining at risk of coronavirus disease 2019 (COVID-19). Neutralizing monoclonal antibody (mAb) that binds the conserved S2 subunit of the SARS-CoV-2 spike (S) protein alone, or in combination...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4723b260-49d4-50f7-8ad5-f5a83df61e10
- DOI
- 10.1016/j.hlife.2024.02.001
